CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 1,175,000 shares at $14.85 ($17,448,750)
- 4 Planned sale Director sold 25,000 shares at an average $10.30 ($257,450)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 9,460 shares (option exercise)
- 4 Planned sale Director sold 5,000 shares at $10.92 ($54,600)
- 4 Planned sale Director sold 15,000 shares at $9.51 ($142,650)
- 4 Planned sale Director sold 20,000 shares at $10.97 ($219,400)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 13,700 shares (option exercise)
- 4 Other disposition Director disposed of 481,014 shares (other)
- 4 Planned sale Director sold 25,000 shares at an average $12.41 ($310,309)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 30,000 shares at an average $12.79 ($383,550)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 20,000 shares (option exercise)
- 4 Option exercise CH. OPERATING & FINANCIAL OFF. acquired 50,000 shares (option exercise)
- 4 Open-market sale Director sold 25,000 shares at an average $13.38 ($334,500)
- 4 Open-market buy Director bought 640,000 shares at an average $10.74 ($6,871,279)
- 4 Option exercise CH. OPERATING & FINANCIAL OFF. acquired 10,000 shares (option exercise)
Page 5 of 13 · 244 filings